Can HCV infection be cleared?

Lancet

Volumn 352, Issue 9129, 1998, Pages 669-670

  Weiland, O ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SHORT SURVEY;

EID: 0032578286     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)60815-x     Document Type: Short Survey

References (7)

1. G Haydon L Jarvis C Blair Clinical significance of intrahepatic hepatitis C virus in patients with chronic HCV infection Gut 42 1998 570 575
2. A Alberti G Morsica L Chemello Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV Lancet 340 1992 697 698
3. KL Lindsay Therapy of hepatitis C: overview Hepatology 26 suppl 1 1997 71S 77S
4. P Marcellin N Boyer A Gervais Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy Ann Intern Med 127 1997 875 881
5. A Mason L Xu L Guo M Kuhns R Perrillo Molecular basis for persistent hepatitis B virus infection in the liver after clearance of hepatitis B surface antigen Hepatology 27 1998 1736 1742
6. A Hawkins F Davidson P Simmonds Comparison of plasma virus loads among individuals infected withepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay version 1 and 2, Roche Monitor assay, and an in-house limiting dilution method J Clin Microbiol 35 1997 187 192
7. O Reichard G Norkrans A Frydén J-H Braconier A Sönnerborg O Weiland, Comparison of three quantitative HCV RNA assays—accuracy of baseline viral load to predict treatment outcome of chronic hepatitis C. J Med Virol (in press).